EUROPE RETINAL IMAGING DEVICES MARKET FORECAST 2023-2032

The Europe retinal imaging devices market growth analysis includes the assessment of Spain, France, Germany, Belgium, Italy, Poland, the United Kingdom, and Rest of Europe. In the United Kingdom, rising demographic shifts, marked by an aging population and evolving lifestyle patterns, have contributed to the increasing prevalence of eye diseases, particularly age-related conditions such as AMD and diabetic retinopathy. As per the UK Census of 2021, the population aged 65 and above has grown from 9.2 million in 2011 to surpass 11 million in 2021, with the proportion of individuals aged 65 and older rising from 16.4% to 18.6%. Accordingly, the growing need for precise disease assessment is fueling the launch of enhanced retinal imaging devices capable of delivering accurate and early diagnoses.

Furthermore, France is experiencing a rise in age-related eye disorders due to its aging population. As individuals grow older, their vulnerability to retinal illnesses increases, underscoring the importance of routine screenings and eye examinations. According to Le Monde, 2023 is expected to witness 26% of France’s population aged over 60. This demographic trend is projected to escalate to approximately one-third by 2040, presenting a significant demographic shift that will pose considerable economic and social challenges in the coming decades. Such factors offer growth opportunities for the analyzed market. 

The Europe retinal imaging devices market segmentation includes end use and device type. The end use segment includes ambulatory surgery center, hospital, ophthalmic center, and other end uses.

Hospitals employ retinal imaging devices equipped with advanced technology, including optical coherence tomography (OCT), fundus cameras, and fluorescein angiography systems, to conduct thorough assessments of patients’ ocular health. These cutting-edge instruments enable precise examination and evaluation of the retina, facilitating early identification of conditions such as diabetic retinopathy, age-related macular degeneration, and retinal detachments. By incorporating retinal imaging technologies into their diagnostic protocols, hospitals ensure accurate diagnoses, support treatment determinations, and monitor the progression of retinal diseases over time. 

Some of the prominent firms in the Europe retinal imaging devices market are Carl Zeiss Meditec AG, Optos plc, Canon Inc, etc.

Carl Zeiss Meditec AG is a medical technology company specializing in solutions for the treatment and diagnosis of eye conditions and diseases. The company’s product portfolio includes a vast range of surgical microscopes, ophthalmic imaging systems, and other innovative medical devices intended to support advancing ophthalmic research and enhance patient care quality. It operates on a global scale with a large presence in the Middle East & Africa, North America, Asia-Pacific, and Europe. The company has its headquarters in Jena, Germany.

One of its key products, PLEX Elite 9000Swpt-Source OCT, is an imaging platform that captures high-resolution images of the optic nerve, choroid, and retina using swept-source technology.